B Young, TT Tan,
YS Leo - The Lancet. Infectious Diseases, 2021 - ncbi.nlm.nih.gov
… COVID-19.1, 2 Interim results from the WHO-led, open-label, randomised SOLIDARITY trial
3 of patients with COVID-19 … For now, remdesivir is an important COVID-19 treatment option …